Detecting circulating tumor DNA in renal cancer: An open challenge
- 1 April 2017
- journal article
- research article
- Published by Elsevier in Experimental and Molecular Pathology
- Vol. 102 (2) , 255-261
Abstract
No abstract availableKeywords
Funding Information
- Swiss National Cancer Foundation (3238BO-10314)
This publication has 26 references indexed in Scilit:
- Molecular Genetics of Clear-Cell Renal Cell CarcinomaJournal of Clinical Oncology, 2014
- Monitoring tumor-derived cell-free DNA in patients with solid tumors: Clinical perspectives and research opportunitiesCancer Treatment Reviews, 2014
- Detection of Circulating Tumor DNA in Early- and Late-Stage Human MalignanciesScience Translational Medicine, 2014
- Quantification of Plasma Cell-Free DNA1in Predicting Therapeutic Efficacy of Sorafenib on Metastatic Clear Cell Renal Cell CarcinomaDisease Markers, 2013
- Noninvasive Identification and Monitoring of Cancer Mutations by Targeted Deep Sequencing of Plasma DNAScience Translational Medicine, 2012
- Serum cell‐free DNA in renal cell carcinomaCancer, 2011
- Patterns of Gene Expression and Copy-Number Alterations in von-Hippel Lindau Disease-Associated and Sporadic Clear Cell Carcinoma of the KidneyCancer Research, 2009
- Circulating mutant DNA to assess tumor dynamicsNature Medicine, 2008
- Quantitative Analysis of Plasma DNA in Colorectal Cancer PatientsAnnals of the New York Academy of Sciences, 2006
- Detection and quantification of mutations in the plasma of patients with colorectal tumorsProceedings of the National Academy of Sciences of the United States of America, 2005